These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2117850)

  • 1. Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis.
    Lashner BA; Silverstein MD
    Am J Gastroenterol; 1990 Sep; 85(9):1088-95. PubMed ID: 2117850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants.
    de Zwart IM; Griffioen G; Shaw MP; Lamers CB; de Roos A
    Clin Radiol; 2001 May; 56(5):401-9. PubMed ID: 11384140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectosigmoid polyps as markers of proximal colonic neoplasms: a cost benefit analysis of different diagnostic protocols.
    Arrigoni A; Pennazio M; Rossini FP
    Anticancer Res; 1995; 15(2):563-7. PubMed ID: 7763038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of diagnostic examinations for colorectal polyps.
    Menardo G
    Tech Coloproctol; 2004 Dec; 8 Suppl 2():s273-5. PubMed ID: 15666105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
    Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
    Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of colorectal cancer screening.
    McMahon PM; Bosch JL; Gleason S; Halpern EF; Lester JS; Gazelle GS
    Radiology; 2001 Apr; 219(1):44-50. PubMed ID: 11274533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for occult cancer in patients with idiopathic deep vein thrombosis--a decision analysis.
    Barosi G; Marchetti M; Dazzi L; Quaglini S
    Thromb Haemost; 1997 Nov; 78(5):1319-26. PubMed ID: 9408012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonoscopy evaluations: justification by cost?
    Rex DK; Mark D; Clarke B; Lappas JC; Lehman GA
    Am J Gastroenterol; 1996 Mar; 91(3):614-5. PubMed ID: 8633528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer. Which test is best?
    Cahill BA
    Adv Nurse Pract; 2005 Jan; 13(1):71-4. PubMed ID: 15679298
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for screening for colorectal carcinoma.
    England WL; Halls JJ; Hunt VB
    Med Decis Making; 1989; 9(1):3-13. PubMed ID: 2492069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of cost-effective strategies in colorectal cancer screening].
    Dervaux B; Eeckhoudt L; Lebrun T; Sailly JC
    Rev Epidemiol Sante Publique; 1992; 40(5):296-306. PubMed ID: 1480806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.